TNNT1

mutation — cross-omics
Cross-omicsMUTATION → DRUGCell-linePairwise association · TCGA cohorts

Across TCGA cell cohorts, TNNT1 mutation is significantly associated with the drug of many other genes, with 15 significant associations in total. LARGE_INTESTINE shows the largest number of these associations.

The most reproducible TNNT1-associated genes across cancer lineages are Niraparib, 123829, and Dihydrorotenone. Each is linked with TNNT1 in more than 1 cancer types. Because this analysis shows association rather than direction, both TNNT1-to-partner and partner-to-TNNT1 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, Niraparib grouped by TNNT1-low versus TNNT1-high in LARGE_INTESTINE.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (TNNT1→partner) and Y-score (partner→TNNT1) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LARGE_INTESTINENiraparib →+0.412+2.646.020.04731
LARGE_INTESTINE123829 →+0.576+2.649.048.04631
LARGE_INTESTINEDihydrorotenone →+0.406+2.649.049.04631
LARGE_INTESTINEKRAS (G12C) Inhibitor-12 →+0.527+2.646.035.04731
LARGE_INTESTINECZC24832 →+0.301+2.646.020.04711
LARGE_INTESTINEWnt-C59 →+0.373+2.646.033.04711
Each partner links to its Q-omics profile. Showing the 6 strongest of 15 associations by consensus.

Niraparib by TNNT1 expression — LARGE_INTESTINE

Box plot of Niraparib in TNNT1-low vs TNNT1-high samples in LARGE_INTESTINE.

Explore this box plot interactively →

Exploration